“Snake-oil,” “quack medicine,” and “industrially cultured organisms:” biovalue and the commercialization of human microbiome research
Open Access
- 30 October 2012
- journal article
- Published by Springer Science and Business Media LLC in BMC Medical Ethics
- Vol. 13 (1), 28
- https://doi.org/10.1186/1472-6939-13-28
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- How Patients View ProbioticsJournal of Clinical Gastroenterology, 2012
- The science and regulations of probiotic food and supplement product labelingAnnals of the New York Academy of Sciences, 2011
- Dietary Supplement Use in the United States, 2003–2006Journal of Nutrition, 2011
- The Human Microbiome Project, Personalized Medicine and the Birth of PharmacomicrobiomicsCurrent Pharmacogenomics and Personalized Medicine, 2010
- Position of the American Dietetic Association: Functional FoodsJournal of the American Dietetic Association, 2009
- Helping Patients Make Informed Choices About Probiotics: A Need for ResearchThe American Journal of Gastroenterology, 2009
- A core gut microbiome in obese and lean twinsNature, 2008
- Ethical, legal, and social considerations in conducting the Human Microbiome ProjectGenome Research, 2008
- The Human Microbiome ProjectNature, 2007
- The Visible Human ProjectPublished by Taylor & Francis Ltd ,2003